source
- Artiva Biotherapeutics to cease operations after two deaths in autoimmune cell therapy trialsArtiva Biotherapeutics announced it will wind down and lay off nearly all staff following two patient fatalities in its autoimmune cell therapy trials. The deaths occurred during clinical testing…
- Biopharma optimism climbs after FDA commissioner Makary's exit, survey findsEndpoints Signal released its Q3 Biopharma Sentiment Index, showing the highest level of industry optimism in years, according to a survey of 569 insiders. The index’s regulatory score rose sharpl…